243 related articles for article (PubMed ID: 8981129)
1. Severe ovarian hyperstimulation syndrome (OHSS) and icterus.
Nawroth F; Heinrich J; Bruns U; Wood WG
Hum Reprod; 1996 Nov; 11(11):2441-2. PubMed ID: 8981129
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
[TBL] [Abstract][Full Text] [Related]
3. [A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].
Moosová M; Moos J; Filová V; Pavelková J; Jarosová R; Rezábek K
Ceska Gynekol; 2011 Apr; 76(2):123-7. PubMed ID: 21649996
[TBL] [Abstract][Full Text] [Related]
4. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
5. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
6. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
7. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
8. Severe ovarian hyperstimulation syndrome following salvage of empty follicle syndrome.
Evbuomwan IO; Fenwick JD; Shiels R; Herbert M; Murdoch AP
Hum Reprod; 1999 Jul; 14(7):1707-9. PubMed ID: 10402372
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
Papaleo E; Doldi N; De Santis L; Marelli G; Marsiglio E; Rofena S; Ferrari A
Hum Reprod; 2001 Nov; 16(11):2263-6. PubMed ID: 11679501
[TBL] [Abstract][Full Text] [Related]
10. Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease.
El-Sheikh MM; Hussein M; Fouad S; El-Sheikh R; Bauer O; Al-Hasani S
Eur J Obstet Gynecol Reprod Biol; 2001 Feb; 94(2):245-9. PubMed ID: 11165733
[TBL] [Abstract][Full Text] [Related]
11. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.
Levy T; Orvieto R; Homburg R; Peleg D; Dekel A; Ben-Rafael Z
Hum Reprod; 1996 Jun; 11(6):1177-9. PubMed ID: 8671418
[TBL] [Abstract][Full Text] [Related]
12. Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome.
Oyesanya OA; Parsons JH; Collins WP; Campbell S
Hum Reprod; 1995 Dec; 10(12):3211-12. PubMed ID: 8822446
[TBL] [Abstract][Full Text] [Related]
13. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
14. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome.
Ling SY; Chong KM; Hwang JL
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):70-2. PubMed ID: 17272214
[TBL] [Abstract][Full Text] [Related]
15. Management of overstimulated gonadotrophin cycles with a controlled drift period.
Urman B; Pride SM; Yuen BH
Hum Reprod; 1992 Feb; 7(2):213-7. PubMed ID: 1577933
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries.
Alserri A; Holzer H; Tulandi T
J Obstet Gynaecol Can; 2012 Sep; 34(9):866-869. PubMed ID: 22971456
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures.
Rizk B; Smitz J
Hum Reprod; 1992 Mar; 7(3):320-7. PubMed ID: 1587936
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation syndrome: distinction between local and systemic disease.
Cobellis L; Pecori E; Stradella L; De Lucia E; Messalli EM; Cobellis G
Gynecol Endocrinol; 2003 Apr; 17(2):95-9. PubMed ID: 12737669
[TBL] [Abstract][Full Text] [Related]
19. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
20. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
